Literature DB >> 27338870

Intratumor heterogeneity: predicting and preventing therapeutic resistance.

Demosthenes E Ziogas1,2, Ioannis Zerdes1, Efstathios G Lykoudis3, Georgios Glantzounis4, Dimitrios H Roukos1,4,5.   

Abstract

Keywords:  intratumor clonal diversity; next-generation sequencing; technological genome systems; therapeutic resistance; tumor heterogeneity

Mesh：

Substances：

Year:  2016        PMID： 27338870     DOI： 10.2217/bmm-2016-0044

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  1 in total

1.  Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C.

Authors:  Vincent L Cannataro; Stephen G Gaffney; Carly Stender; Zi-Ming Zhao; Mark Philips; Andrew E Greenstein; Jeffrey P Townsend
Journal:  Oncogene       Date:  2018-02-16       Impact factor: 9.867
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.